if neurological involvement is present, maintenance is every two months Oral therapy is generally not appropriate where absorption is impaired (e.g., pernicious anaemia), as adequate levels cannot be reliably achieved Because B12 is water-soluble and any excess beyond hepatic storage capacity is excreted in the urine, it has a low toxicity profile
UK-wide licensing for human medicines
When administered via injection, SLU-PP-332 demonstrates: Rapid absorption into the bloodstream High bioavailability, with a significant portion of the drug reaching systemic circulation Consistent absorption patterns across different patient populations These absorption characteristics contribute to the potential efficacy of SLU-PP-332 in various therapeutic applications
By following best practices and utilizing quality tools, patients can maximize the benefits of their B12 therapy, supporting energy levels, cognitive function, and overall health
Since no official dosing protocol exists, the protocols below reflect a combination of clinical observation, documented self-experimentation, and what people I trust have used and recommended
It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you